• Aucun résultat trouvé

A journey with cancer

N/A
N/A
Protected

Academic year: 2022

Partager "A journey with cancer"

Copied!
1
0
0

Texte intégral

(1)

778

Canadian Family PhysicianLe Médecin de famille canadien

|

Vol 62: october • octobre 2016

Editorial

Cet article se trouve aussi en français à la page 779.

A journey with cancer

Roger Ladouceur

MD MSc CCMF (SP) FCMF, ASSOCIATE SCIENTIFIC EDITOR At first, it’s nothing—or almost nothing. A cough that

won’t go away; a tiny lump; a pain that feels differ- ent, more persistent than before; blood where there shouldn’t be any; unusual fatigue; unexplained weight loss. The cough will go away, the person says to him- self or herself. The lump is so tiny that it can’t be important; there were only a few drops of blood. It’s normal to be so tired, what with all the responsibil- ity and stress. And who wouldn’t want to lose a few pounds? It will go away, the person says to himself or herself, but then it doesn’t. And so the journey begins.

A trip to the doctor, just to be sure. Just to rule out something sinister. There’s nothing to be worried about, but one never knows. Sometimes, a person sees his or her doctor for an annual checkup, suspecting nothing, because there have been no symptoms, no lit- tle warning signs. In this case, the journey begins here, in the doctor’s office.

There is, in fact, a problem. The person is told that his or her test results are not normal and that addi- tional tests are in order: a scope, a bone scan, com- puted tomography, magnetic resonance imaging, positron emission tomography, a biopsy. The words spot, bump, lump, abnormal cells, and atypical cells are mentioned. And although the word cancer is not used and the doctor speaks reassuringly, the effect is the same. Something is wrong, very wrong. Otherwise, why would all of these extra tests and specialist appointments be happening so quickly? One day, the person felt fine—in perfect health—and the next day he or she is ill, perhaps even gravely ill. How can that be?

Try not to worry, the doctor says. We have a treatment and it should go well.

Treatment begins. Surgery, chemotherapy, radiation, brachytherapy, immunotherapy, Gamma Knife. And then the person finds himself or herself in an oncology unit reclining chair, waiting for treatment according to protocols that have been clearly and carefully defined.

An entire arsenal of therapies for fighting the disease.

For beating it. But mostly for restoring health, as the end goal is healing.

The unknown. As the journey continues, the per- son walks hand in hand with hope and fear. Hope says, maybe this whole thing is a bad dream. Hope

says, maybe the cancer can be beaten. Fear asks, what about that new symptom? Is the cancer back? Either way, there is a long journey of waiting and wondering ahead. For how long? No one knows.

And then it’s back. Sometimes—often—the disease comes back. There is a second or even a third course of chemotherapy. Experimental treatments. Research protocols. Searching the Web for a miracle—for some treatment that has escaped the notice of the specialists.

Perhaps a prohibitively expensive treatment only avail- able in a foreign country. As the disease progresses, the person loses the ability to care for himself or her- self and needs home care and help from others.

The end of the road. And then, there is a realization that the person cannot be cured. His or her caregiv- ers are exhausted and a decision is made to move the person to a facility. There are conversations about not prolonging suffering and about comfort care. Despair.

Palliative sedation. Physician-assisted death.

Not every person with cancer has this journey. Great progress has been made in the treatment of many different types of cancer. Some cancer patients sur- vive. For many, the journey lasts for years. But cancer is such a tenacious disease and it inspires such fear.

Rarely is the word cure used, as if there were a con- stant fear of the cancer coming back and of a journey that will never be over. Instead, the cancer is described as being in remission.

Where are family physicians on this journey? They are mostly at the beginning and at the end. Cancer treatment is highly specialized, well beyond the scope of practice of most family physicians. But that doesn’t explain why they do not accompany their patients, offering help, advice, and support every step of the way.

This month’s issue of Canadian Family Physician fea- tures a series of articles on cancer. I draw your attention to page 821 and the article titled “Patients’ experiences with continuity of cancer care in Canada. Results from the CanIMPACT study.”1 The results of this study under- score the importance of good communication and a positive relationship with front-line care providers.

Family physicians definitely have a role to play throughout the difficult journey awaiting their patients with cancer.

reference

1. Easley J, Miedema B, Carroll JC, O’Brien MA, Manca DP, Grunfeld E. Patients’

experiences with continuity of cancer care in Canada. Results from the CanIMPACT study. Can Fam Physician 2016;62:821-7.

Références

Documents relatifs

National (American and Canadian) or provincial cancer organi- zation guidelines with an evidence-based approach to breast cancer screening and surveillance, posttreatment

The optimal interval for screening in patients with a first-degree family history of CRC must balance the risks of unnecessary procedures and the serious implications of

7,8 In this article, we examine the opportunities and issues these patients might raise, concerns family physicians might have, and what facilitators need to be in place for

2 The members of the Advisory Committee on Family Practice, with support from our staff in the department of Health Policy and Government Relations, have developed advance

The  coursework  over  the  next  several  years  revealed  a  fascinating new world of academic medicine—a plethora  of  articles  and  books  on 

Our study of organizational change in the Alberta health care system includes investigat- ing how Calgary Health Region (a large regional health authority combining

Often in the past, the venue has been the Annual Meeting of North American Primary Care Research Group (NAPCRG); however, we are hop- ing to extend the opportunity of

9-11 Family physicians want to be more involved in all stages of cancer care and believe that their knowledge of patients and families is useful, particularly in mak- ing